SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9873489
Source:
http://linkedlifedata.com/resource/pubmed/id/9873489
Search
Subject
(
63
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0220781
,
umls-concept:C1513016
,
umls-concept:C1707689
,
umls-concept:C1883254
pubmed:issue
16
pubmed:dateCreated
1999-1-28
pubmed:abstractText
A novel series of conformationally constrained matrix metalloprotease inhibitors was identified. The potencies observed for these inhibitors were highly dependent upon the substitution pattern on the caprolactam ring as well as the succinate moiety.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9107377
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Caprolactam
,
http://linkedlifedata.com/resource/pubmed/chemical/Collagenases
,
http://linkedlifedata.com/resource/pubmed/chemical/Indicators and Reagents
,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 1
,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 3
,
http://linkedlifedata.com/resource/pubmed/chemical/Metalloendopeptidases
,
http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Succinates
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0960-894X
pubmed:author
pubmed-author:AlmsteadN GNG
,
pubmed-author:AnastasioM BMB
,
pubmed-author:BarnettB LBL
,
pubmed-author:BradleyR SRS
,
pubmed-author:ChengMM
,
pubmed-author:DunawayC MCM
,
pubmed-author:EYWW
,
pubmed-author:McIverJ MJM
,
pubmed-author:McPhailS JSJ
,
pubmed-author:MielingG EGE
,
pubmed-author:NatchusM GMG
,
pubmed-author:PikusJJ
,
pubmed-author:SniderC ECE
,
pubmed-author:TaiwoY OYO
,
pubmed-author:WahlC TCT
pubmed:issnType
Print
pubmed:day
18
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2077-80
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9873489-Caprolactam
,
pubmed-meshheading:9873489-Collagenases
,
pubmed-meshheading:9873489-Drug Design
,
pubmed-meshheading:9873489-Indicators and Reagents
,
pubmed-meshheading:9873489-Kinetics
,
pubmed-meshheading:9873489-Matrix Metalloproteinase 1
,
pubmed-meshheading:9873489-Matrix Metalloproteinase 3
,
pubmed-meshheading:9873489-Metalloendopeptidases
,
pubmed-meshheading:9873489-Models, Molecular
,
pubmed-meshheading:9873489-Molecular Conformation
,
pubmed-meshheading:9873489-Molecular Structure
,
pubmed-meshheading:9873489-Protease Inhibitors
,
pubmed-meshheading:9873489-Protein Conformation
,
pubmed-meshheading:9873489-Structure-Activity Relationship
,
pubmed-meshheading:9873489-Succinates
pubmed:year
1998
pubmed:articleTitle
Design and synthesis of conformationally-constrained MMP inhibitors.
pubmed:affiliation
Procter and Gamble Pharmaceuticals, Health Care Research Center, Mason, OH 45040, USA.
pubmed:publicationType
Journal Article